Itama Ranoraya PT

Itama Ranoraya PT has a debt-to-equity ratio of 0.47, indicating a relatively conservative capital structure with a moderate level of leverage. The company's liquidity is assessed as medium, and its current ratio of 1.28 suggests it has sufficient short-term assets to cover its short-term liabilities, though not with a large buffer. The company's profitability is modest, with a return on equity of 0.97% and a return on assets of 0.38%. These figures are below the typical thresholds for strong performance in the healthcare services and equipment industry, suggesting that the company is not generating significant returns relative to its equity and asset base. Itama Ranoraya PT's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no detailed geographic breakdown provided. This lack of diversification could expose the company to higher risks if demand in its primary market fluctuates. The company's growth trajectory is not clearly defined in the available data, as there are no specific numeric deltas provided for the current or next fiscal year. However, the company's operating cash flow is negative, which may indicate challenges in generating sufficient cash from operations to support growth initiatives. The risk assessment for Itama Ranoraya PT highlights a medium liquidity risk and a low dilution risk. The company's net cash position is negative after accounting for total debt, which could impact its ability to meet short-term obligations without additional financing. There are no recent events or filings mentioned in the provided data that would significantly impact the company's operations or financial position. The absence of recent transcripts or filings suggests a lack of public disclosures that could provide further insight into the company's strategic direction or operational performance.